Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.210 | 1.990 | 0.780 |
Stocks | 98.790 | 98.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.619 | 37.516 |
Price to Book | 4.522 | 5.365 |
Price to Sales | 4.222 | 5.581 |
Price to Cash Flow | 25.181 | 27.701 |
Dividend Yield | 0.782 | 0.595 |
5 Years Earnings Growth | 14.219 | 19.762 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 79.220 | 96.130 |
Energy | 7.290 | 7.290 |
Technology | 6.940 | 6.940 |
Consumer Defensive | 5.970 | 5.970 |
Basic Materials | 0.590 | 4.357 |
Number of long holdings: 23
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
RPG Life Sciences Limited | INE105J01010 | 8.78 | 1,991.95 | -1.98% | |
Aster DM Healthcare | INE914M01019 | 7.17 | 432.30 | +0.97% | |
Reliance Industries | INE002A01018 | 6.98 | 1,265.40 | +3.47% | |
Aurobindo Pharma | INE406A01037 | 6.94 | 1,223.70 | +0.30% | |
Pfizer Ltd | INE182A01018 | 6.68 | 5,225.65 | +1.84% | |
HFCL | INE548A01028 | 6.65 | 126.28 | -0.83% | |
GlaxoSmithkline Pharma | INE159A01016 | 6.26 | 2,411.80 | +1.78% | |
Ipca Laboratories | INE571A01038 | 6.21 | 1,591.35 | +1.13% | |
Glenmark Life Sciences | INE03Q201024 | 5.95 | 1,045.65 | -3.19% | |
Zydus Wellness | INE768C01010 | 5.72 | 1,916.35 | -0.84% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF966L01689 | 263.31B | 28.35 | 29.29 | 21.94 | ||
INF966L01051 | 263.31B | 27.36 | 27.68 | 21.12 | ||
Quant Mid Cap Fund Growth | 89.41B | 22.57 | 25.82 | 18.87 | ||
INF966L01887 | 89.41B | 23.70 | 27.92 | 20.03 | ||
Quant Consumption Fund Growth | 75.14B | 22.39 | 21.13 | 19.96 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review